Ojewole John A O
Department of Pharmacology, School of Pharmacy and Pharmacology, Faculty of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.
Phytother Res. 2008 Jan;22(1):91-6. doi: 10.1002/ptr.2272.
Extracts of Hypoxis hemerocallidea Fisch. & C. A. Mey. (Hypoxidaceae) corm (popularly known as 'African potato') are extensively used in South African traditional medicines for the treatment, management and/or control of an array of human ailments, including childhood convulsions and epilepsy. This study examined the anticonvulsant activity of the plant's corm aqueous extract (APE, 50-800 mg/kg i.p.) against pentylenetetrazole (PTZ)-, picrotoxin (PCT)- and bicuculline (BCL)-induced seizures in mice. Phenobarbitone and diazepam were used as reference anticonvulsant drugs for comparison. Like the reference antiseizure drugs used, Hypoxis hemerocallidea corm aqueous extract (APE, 100-800 mg/kg i.p.) significantly delayed (p < 0.05-0.001) the onset of, and antagonized, pentylenetetrazole (PTZ)-induced seizures. The plant's corm aqueous extract (APE, 100-800 mg/kg i.p.) also profoundly antagonized picrotoxin (PCT)-induced seizures, but only weakly antagonized bicuculline (BCL)-induced seizures. Although the data obtained in the present study do not provide conclusive evidence, it would appear that 'African potato' aqueous extract (APE) produces its antiseizure effect by enhancing GABAergic neurotransmission and/or action in the brain. The results of this laboratory animal study indicate that APE possesses anticonvulsant activity in the mammalian experimental model used and, therefore, tend to suggest that the herb may be used as a natural supplementary remedy in the management, control and/or treatment of childhood convulsions and epilepsy. In conclusion, the findings of this study indicate that Hypoxis hemerocallidea corm aqueous extract possesses anticonvulsant activity, and thus lend pharmacological credence to the suggested folkloric, anecdotal ethnomedical uses of the herb in the management of childhood convulsions and epilepsy in some rural communities of South Africa.
仙茅(Hypoxis hemerocallidea Fisch. & C. A. Mey.,仙茅科)球茎提取物(俗称“非洲土豆”)在南非传统医学中被广泛用于治疗、管理和/或控制一系列人类疾病,包括儿童惊厥和癫痫。本研究考察了该植物球茎水提取物(APE,腹腔注射剂量为50 - 800 mg/kg)对小鼠戊四氮(PTZ)、印防己毒素(PCT)和荷包牡丹碱(BCL)诱导惊厥的抗惊厥活性。苯巴比妥和地西泮用作参考抗惊厥药物进行比较。与所使用的参考抗癫痫药物一样,仙茅球茎水提取物(APE,腹腔注射剂量为100 - 800 mg/kg)显著延迟(p < 0.05 - 0.001)并拮抗戊四氮(PTZ)诱导的惊厥发作。该植物球茎水提取物(APE,腹腔注射剂量为100 - 800 mg/kg)也能显著拮抗印防己毒素(PCT)诱导的惊厥,但仅微弱拮抗荷包牡丹碱(BCL)诱导的惊厥。尽管本研究获得的数据未提供确凿证据,但“非洲土豆”水提取物(APE)似乎是通过增强大脑中的γ-氨基丁酸能神经传递和/或作用来产生其抗惊厥作用。这项实验动物研究的结果表明,APE在所使用的哺乳动物实验模型中具有抗惊厥活性,因此,倾向于表明该草药可作为一种天然补充疗法用于儿童惊厥和癫痫的管理、控制和/或治疗。总之,本研究结果表明仙茅球茎水提取物具有抗惊厥活性,从而为该草药在南非一些农村社区用于儿童惊厥和癫痫管理的民间传说、轶事性民族医学用途提供了药理学依据。